"Disease Management" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)
| Descriptor ID |
D019468
|
| MeSH Number(s) |
N04.590.607
|
| Concept/Terms |
Disease Management- Disease Management
- Disease Managements
- Management, Disease
- Managements, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Management".
Below are MeSH descriptors whose meaning is more specific than "Disease Management".
This graph shows the total number of publications written about "Disease Management" by people in this website by year, and whether "Disease Management" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 3 | 3 |
| 2007 | 1 | 4 | 5 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 4 | 4 |
| 2011 | 2 | 7 | 9 |
| 2012 | 3 | 4 | 7 |
| 2013 | 2 | 6 | 8 |
| 2014 | 4 | 6 | 10 |
| 2015 | 9 | 14 | 23 |
| 2016 | 5 | 16 | 21 |
| 2017 | 12 | 14 | 26 |
| 2018 | 9 | 15 | 24 |
| 2019 | 7 | 19 | 26 |
| 2020 | 6 | 27 | 33 |
| 2021 | 4 | 14 | 18 |
| 2022 | 1 | 1 | 2 |
| 2023 | 2 | 1 | 3 |
| 2024 | 2 | 9 | 11 |
| 2025 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Management" by people in Profiles.
-
Hepatosplenic T-cell lymphoma in children and adolescents. Blood Adv. 2025 Apr 22; 9(8):1847-1858.
-
Peripheral T-cell lymphoma-NOS in children and adolescents: a review from the Children's Oncology Group NHL Committee. Blood Adv. 2025 Mar 25; 9(6):1420-1431.
-
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts. Blood Adv. 2025 Mar 25; 9(6):1442-1451.
-
TP53 -Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol. 2025 Jun; 100 Suppl 4:88-115.
-
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative Neoplasms. Clin Lymphoma Myeloma Leuk. 2025 Jul; 25(7):484-493.
-
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024. J Natl Compr Canc Netw. 2024 Nov; 22(9):582-592.
-
Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia. Haematologica. 2025 Apr 01; 110(4):828-839.
-
Secondary Mitral Regurgitation: Updated Review with Focus on Percutaneous Interventional Management. J Card Fail. 2024 Oct; 30(10):1302-1318.
-
Variance Between Clinical Guidance and Real-World Management of Metabolic Dysfunction-associated Steatotic Liver Disease in the United States. Clin Gastroenterol Hepatol. 2025 Feb; 23(2):374-376.e3.
-
Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. JACC Heart Fail. 2024 Aug; 12(8):1328-1342.